{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:45Z","timestamp":1792173345956,"version":"4.4.0"},"reference-count":24,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>In the MiTy (Metformin in Women With Type 2 Diabetes in Pregnancy) randomized trial of metformin versus placebo added to insulin, we found numerous benefits with metformin but identified an increased proportion of infants who were small for gestational age (SGA). We aimed to determine the predictors of SGA in order to individualize care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Using logistic regression, we assessed baseline maternal characteristics as predictors of SGA. We compared maternal\/neonatal outcomes in SGA metformin and placebo groups using the t, \u03c72, or Fisher exact test, as appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Among the 502 mothers, 460 infants were eligible for this study. There were 30 infants with SGA in the metformin group (12.9%) and 15 in the placebo group (6.6%) (P = 0.026). Among SGA infants, those in the metformin group were delivered significantly later than those in the placebo group (37.2 vs. 35.3 weeks; P = 0.038). In adjusted analyses, presence of a comorbidity (chronic hypertension and\/or nephropathy) (odds ratio [OR] 3.05; 95% CI 1.58\u20135.81) and metformin use (OR 2.26; 95% CI 1.19\u20134.74) were predictive of SGA. The absolute risk of SGA was much higher in women receiving metformin with comorbidity compared with women receiving metformin without comorbidity (25.0% vs. 9.8%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In this study, we observed a high percentage of SGA births among women with type 2 diabetes and chronic hypertension and\/or nephropathy who were treated with metformin. Therefore, with the aim of reducing SGA, it is reasonable to be cautious in our use of metformin in those with type 2 diabetes and chronic hypertension or nephropathy in pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc22-0013","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:22:50Z","timestamp":1654600970000},"page":"1532-1539","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":31,"title":["Determinants of Small for Gestational Age in Women With Type 2 Diabetes in Pregnancy: Who Should Receive Metformin?"],"prefix":"10.2337","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-7584","authenticated-orcid":false,"given":"Denice S.","family":"Feig","sequence":"first","affiliation":[{"name":"1Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"2Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada"},{"name":"3Sinai Health System, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-1876","authenticated-orcid":false,"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[{"name":"1Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"2Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada"},{"name":"3Sinai Health System, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Asztalos","sequence":"additional","affiliation":[{"name":"4Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois E.","family":"Donovan","sequence":"additional","affiliation":[{"name":"6Departments of Medicine and Obstetrics & Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"7Alberta Children\u2019s Hospital Research Institute, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakesh S.","family":"Shah","sequence":"additional","affiliation":[{"name":"3Sinai Health System, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"8Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Johanna","family":"Sanchez","sequence":"additional","affiliation":[{"name":"4Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"5Sunnybrook Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"1Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"9Department of Medicine, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie E.","family":"Murphy","sequence":"additional","affiliation":[{"name":"1Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"2Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada"},{"name":"3Sinai Health System, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"10Department of Obstetrics & Gynecology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"2022070714525631200_B1","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0140-6736(02)08599-9","article-title":"Type 2 diabetes in pregnancy: a growing concern","volume":"359","author":"Feig","year":"2002","journal-title":"Lancet"},{"key":"2022070714525631200_B2","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dc13-2717","article-title":"Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010","volume":"37","author":"Feig","year":"2014","journal-title":"Diabetes Care"},{"key":"2022070714525631200_B3","first-page":"1081","article-title":"Diabetes and pregnancy: national trends over a 15 year period","volume":"61","author":"Mackin","year":"2018","journal-title":"Diabetologia"},{"key":"2022070714525631200_B4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022070714525631200_B5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022070714525631200_B6","first-page":"323","article-title":"Morbidity and mortality in small-for-gestational-age infants: a secondary analysis of nine MFMU Network studies","volume":"34","author":"Mendez-Figueroa","year":"2017","journal-title":"Am J Perinatol"},{"key":"2022070714525631200_B7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/uog.12391","article-title":"Neurodevelopmental outcome of full-term small-for-gestational-age infants with normal placental function","volume":"42","author":"Savchev","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2022070714525631200_B8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00399095","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth","volume":"36","author":"Barker","year":"1993","journal-title":"Diabetologia"},{"key":"2022070714525631200_B9","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"2022070714525631200_B10","doi-asserted-by":"crossref","first-page":"198.e1","DOI":"10.1016\/j.ajog.2017.04.020","article-title":"The clinical significance of an estimated fetal weight below the 10th percentile: a comparison of outcomes of &lt;5th vs 5th-9th percentile","volume":"217","author":"Mlynarczyk","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2022070714525631200_B11","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/jum.14577","article-title":"Significance and outcomes of fetal growth restriction below the 5th percentile compared to the 5th to 10th percentiles on midgestation growth ultrasonography","volume":"37","author":"Zhang-Rutledge","year":"2018","journal-title":"J Ultrasound Med"},{"key":"2022070714525631200_B12","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.ajog.2011.10.878","article-title":"Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions","volume":"206","author":"Bateman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2022070714525631200_B13","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"2022070714525631200_B14","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2017.12.235","article-title":"Chronic hypertension: first-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age","volume":"218","author":"Nzelu","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2022070714525631200_B15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/uog.17553","article-title":"Association of chronic hypertension with birth of small-for-gestational-age neonate","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2022070714525631200_B16","doi-asserted-by":"crossref","first-page":"333.e1","DOI":"10.1016\/j.ajog.2012.06.066","article-title":"The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes","volume":"207","author":"Yanit","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2022070714525631200_B17","first-page":"EP564","article-title":"Small for gestational age and gestational diabetes: should we be more permissive? (Abstract)","volume":"49","author":"Bettencourt-Silva","year":"2017","journal-title":"Endocrine Abstracts"},{"key":"2022070714525631200_B18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/14767050903216025","article-title":"Pre-pregnancy body mass index, maternal weight gain during pregnancy and risk of small-for-gestational age birth: results from a case-control study in Italy","volume":"23","author":"Ricci","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022070714525631200_B19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/AOG.0b013e31828aea03","article-title":"Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines","volume":"121","author":"Johnson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2022070714525631200_B20","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/dc12-1232","article-title":"Impact of restricted maternal weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes","volume":"36","author":"Asbj\u00f6rnsd\u00f3ttir","year":"2013","journal-title":"Diabetes Care"},{"key":"2022070714525631200_B21","doi-asserted-by":"crossref","first-page":"e010984","DOI":"10.1136\/bmjopen-2015-010984","article-title":"Small-for-gestational age and its association with maternal blood glucose, body mass index and stature: a perinatal cohort study among Chinese women","volume":"6","author":"Leng","year":"2016","journal-title":"BMJ Open"},{"key":"2022070714525631200_B22","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/dc11-0241","article-title":"Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged?","volume":"34","author":"Hernandez","year":"2011","journal-title":"Diabetes Care"},{"key":"2022070714525631200_B23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2337\/dc17-0391","article-title":"The association of falling insulin requirements with maternal biomarkers and placental dysfunction: a prospective study of women with preexisting diabetes in pregnancy","volume":"40","author":"Padmanabhan","year":"2017","journal-title":"Diabetes Care"},{"key":"2022070714525631200_B24","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.1016\/j.ajog.2017.12.011","article-title":"Customized growth charts: rationale, validation and clinical benefits","volume":"218","author":"Gardosi","year":"2018","journal-title":"Am J Obstet Gynecol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/7\/1532\/685184\/dc220013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/7\/1532\/685184\/dc220013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T10:55:27Z","timestamp":1657191327000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/45\/7\/1532\/147062\/Determinants-of-Small-for-Gestational-Age-in-Women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,6]]},"published-print":{"date-parts":[[2022,7,7]]}},"URL":"https:\/\/doi.org\/10.2337\/dc22-0013","relation":{},"ISSN":["0149-5992"],"issn-type":[{"value":"0149-5992","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,6]]}}}